Metal ions as regulators of the conformation and function of the tumour suppressor protein p53: Implications for carcinogenesis

Proceedings of the Nutrition Society

Volumn 58, Issue 3, 1999, Pages 565-571

  Méplan, Catherine ^a   Verhaegh, Gerald ^a,c   Richard, Marie Jeanne ^b   Hainaut, Pierre ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b HÔPITAL MICHALLON   (France)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cadmium; Carcinogenesis; Tumour suppresser protein p53; Zinc

Indexed keywords

CADMIUM; CARCINOGEN; DNA; METAL ION; PROTEIN P53; ZINC;

CARCINOGENESIS; CELL CYCLE; CELL STRAIN MCF 7; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENETIC TRANSCRIPTION; GENOTOXICITY; HUMAN; HUMAN CELL; OXIDATION REDUCTION REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0032732342     PISSN: 00296651     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0029665199000749     Document Type: Conference Paper

References (33)

1. Agarwal ML, Taylor WR, Chernov MV, Chernova OB & Stark GR (1998) The p53 network. Journal of Biological Chemistry 273, 1-4.
2. An WG, Kanekal M, Simon MC, Maltepe E, Blagosklonny MV & Neckers LM (1998) Stabilization of wild-type p53 by hypoxia-inducible factor 1 alpha. Nature 392, 405-408.
3. Calmels S, Hainaut P & Ohshima H (1997) Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Research 57, 3365-3369.
4. Cho Y, Gorina S, Jeffrey PD & Pavletich NP (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science 265, 346-355.
5. Fong LY, Lau KM, Huebner K & Magee PN (1997) Induction of esophageal tumors in zinc-deficient rats by single low doses of N-nitrosomethylbenzylamine (NMBA): analysis of cell proliferation, and mutations in H-ras and p53 genes. Carcinogenesis 18, 1477-1484.
6. Funk WD, Pak DT, Karas RH, Wright WE & Shay JW (1992) A transcriptionally active DNA-binding site for human p53 protein complexes. Molecular and Cellular Biology 12, 2866-2871.
7. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW & Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91.
8. Greenblatt MS, Bennett WP, Hollstein M & Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Research 54, 4855-4878.
9. Gu W & Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
10. Hainaut P, Hernandez T, Robinson A, Rodriguez-Tome P, Flores T, Hollstein M, Harris CC & Montesano R (1998) IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools. Nucleic Acids Research 26, 205-213.
11. Hainaut P & Hollstein M (1999) p53 and human cancer: the first ten thousand mutations. Advances in Cancer Research 77, 81-137.
12. Hainaut P & Milner J (1993a) A structural role for metal ions in the 'wild-type' conformation of the tumor suppressor protein p53. Cancer Research 53, 1739-1742.
13. Hainaut P & Milner J (1993b) Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Research 53, 4469-4473.
14. Hainaut P, Rolley N, Davies M & Milner J (1995) Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. Oncogene 10, 27-32.
15. Haupt Y, Maya R, Kazaz A & Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
16. Hernandez TM & Hainaut P (1998) Tumor-specific mutation spectra in the human p53 gene: from carcinogen 'fingerprints' to functional consequences. Environmental Carcinogenesis and Ecotoxicology Reviews C 16, 31-45.
17. International Agency for Cancer Research (1993) IARC Monographs on the Evaluation of Carcinogenic Risks no. 58. Beryllium, Cadmium, Mercury and Exposures in the Glass Manufacturing Industry. Lyon: IARC.
18. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S & Prives C (1997) Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes and Development 11, 558-570.
19. Knudson AGJ (1971) Mutation and cancer: statistical study of retinoblastoma. Proceedings of the National Academy of Sciences USA 68, 820-823.
20. Kubbutat MH, Jones SN & Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387, 299-303.
21. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358, 15-16.
22. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
23. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW & Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362, 857-860.
24. Polyak K, Xia Y, Zweier JL, Kinzler KW & Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389, 300-305.
25. Shieh SY, Ikeda M, Taya Y & Prives C (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325-334.
26. Siliciano JD, Canman CE, Taya Y, Sakaguchi K, Appella E & Kastan MB (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes and Development 11, 3471-3481.
27. Vallee BL (1991) Introduction to metallothionein. Methods in Enzymology 205, 3-7.
28. Verhaegh GW, Parat MO, Richard MJ & Hainaut P (1998) Modulation of p53 protein conformation and DNA-binding activity by intracellular chelation of zinc. Molecular Carcinogenesis 21, 205-214.
29. Verhaegh GW, Richard MJ & Hainaut P (1997) Regulation of p53 by metal ions and by antioxidants: dithiocarbamate down-regulates p53 DNA-binding activity by increasing the intracellular level of copper. Molecular and Cellular Biology 17, 5699-5706.
30. Wahrendorf J, Munoz N, Lu JB, Thurnham DI, Crespi M & Bosch FX (1988) Blood, retinol and zinc riboflavin status in relation to precancerous lesions of the esophagus: findings from a vitamin intervention trial in the People's Republic of China. Cancer Research 48, 2280-2283.
31. Waterman MJ, Stavridi ES, Waterman JL & Halazonetis TD (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nature Genetics 19, 175-178.
32. Woo RA, McLure KG, Lees-Miller SP, Rancourt DE & Lee PW (1998) DNA-dependent protein kinase acts upstream of p53 in response to DNA damage Nature 394, 700-704.
33. Wu J, Forbes JR, Chen HS & Cox DW (1994) The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nature Genetics 7, 541-545.